Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,621 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inflammation, endothelium, and coagulation in sepsis.
Schouten M, Wiersinga WJ, Levi M, van der Poll T. Schouten M, et al. Among authors: levi m. J Leukoc Biol. 2008 Mar;83(3):536-45. doi: 10.1189/jlb.0607373. Epub 2007 Nov 21. J Leukoc Biol. 2008. PMID: 18032692 Review.
Effects of different plasma substitutes on blood coagulation: a comparative review.
de Jonge E, Levi M. de Jonge E, et al. Among authors: levi m. Crit Care Med. 2001 Jun;29(6):1261-7. doi: 10.1097/00003246-200106000-00038. Crit Care Med. 2001. PMID: 11395618 Review.
Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation.
Levi M, de Jonge E, van der Poll T. Levi M, et al. Crit Care Med. 2001 Jul;29(7 Suppl):S90-4. doi: 10.1097/00003246-200107001-00028. Crit Care Med. 2001. PMID: 11445740 Review.
Coagulation factor XI as a novel target for antithrombotic treatment.
Löwenberg EC, Meijers JC, Monia BP, Levi M. Löwenberg EC, et al. Among authors: levi m. J Thromb Haemost. 2010 Nov;8(11):2349-57. doi: 10.1111/j.1538-7836.2010.04031.x. J Thromb Haemost. 2010. PMID: 20727068 Review.
Measuring activated protein C in plasma to assess its role as a critical modulator of coagulation and inflammation.
Levi M. Levi M. J Thromb Haemost. 2003 Apr;1(4):643-4. doi: 10.1046/j.1538-7836.2003.00152.x. J Thromb Haemost. 2003. PMID: 12871395 No abstract available.
Recombinant human activated protein C (Xigris).
Levi M, De Jonge E, van der Poll T. Levi M, et al. Int J Clin Pract. 2002 Sep;56(7):542-5. Int J Clin Pract. 2002. PMID: 12296618
Cancer and DIC.
Levi M. Levi M. Haemostasis. 2001;31 Suppl 1:47-8. Haemostasis. 2001. PMID: 11990477 No abstract available.
Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
de Jonge E, van der Poll T, Kesecioglu J, Levi M. de Jonge E, et al. Among authors: levi m. Semin Thromb Hemost. 2001 Dec;27(6):667-74. doi: 10.1055/s-2001-18871. Semin Thromb Hemost. 2001. PMID: 11740690 Review.
Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia.
de Jonge E, Dekkers PE, Creasey AA, Hack CE, Paulson SK, Karim A, Kesecioglu J, Levi M, van Deventer SJ, van der Poll T. de Jonge E, et al. Among authors: levi m. J Infect Dis. 2001 Jun 15;183(12):1815-8. doi: 10.1086/320723. Epub 2001 May 11. J Infect Dis. 2001. PMID: 11372037 Clinical Trial.
Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease.
Friederich PW, Wever PC, Briët E, Doorenbos CJ, Levi M. Friederich PW, et al. Among authors: levi m. Am J Hematol. 2001 Apr;66(4):292-4. doi: 10.1002/ajh.1060. Am J Hematol. 2001. PMID: 11279642
1,621 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback